(888) 552-6760 SCHEDULE AN APPOINTMENT

Jeffrey S. Yoshida,

Urologist

Biography photo
Location
City of Hope Orange County Lennar Foundation Cancer Center
1000 Five Point
Irvine, CA 92618
Newport Beach
1601 Avocado Avenue
Newport Beach, CA 92660
Seacliff
2100 Main Street #300
Huntington Beach, CA 92648
Academic Appointments
  • Clinical Professor, Division of Urology and Urologic Oncology, Department of Surgery
  • Medical Director, Division of Urologic Surgery, City of Hope Orange County
About Me

Jeffrey S. Yoshida, M.D. recognizes that each of his patients carries a unique personality and background -- as does their cancer. For that reason, he believes that medical care should be customized and specific to the individual.

Dr. Yoshida received his medical degree from Loma Linda University. Soon after, he pursued a general surgery internship at Harbor-UCLA Medical Center, followed by a residency in urology at Loma Linda. He completed a laparoscopic oncology/robotic surgery fellowship at City of Hope, where he was the first fellow ever to be trained in robotic surgery.

Before becoming City of Hope Orange County’s medical director of urologic surgery, Dr. Yoshida held a position as associate clinical professor at City of Hope. He also worked at Hoag Family Cancer Institute as the medical director of urologic oncology, where he was honored with an endowed chair in urologic oncology.

Today, Dr. Yoshida is excited to use the latest advances in robotic surgery and molecular imaging to ensure his patients receive the best care possible. He continues to earn renown as an expert in this gentler approach to removing tumors, which typically offers patients fewer side effects and faster recovery compared to open procedures.

In his spare time, Yoshida enjoys surfing and spending time with his family and their dog.

Patient ratings
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy at our comprehensive care and research centers. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.